Beckman Coulter Addresses COVID-19 Testing From Multiple Angles
The company expects testing for IgM antibodies will be useful in areas where PCR testing is not keeping up with demand.
You may also be interested in...
The US FDA’s diagnostics chief says the agency isn’t seeing many submissions for rapid antigen tests, but is eager to authorize them.
Autobio’s test reportedly only correctly identified half the positive SARS-CoV-2 antibody samples in an NIH evaluation.
While the main role of SARS-CoV-2 antibody testing is currently limited to determining exposure to the virus in populations, the scientific community is working hard to define the neutralizing properties of the antibodies detected, and the duration of the immune response. As a result, antibody testing could be here to stay for the long term for monitoring populations, testing vaccines and selecting patients for trials of a variety of new therapies to treat numerous conditions.